The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.
Deirdre WeymannJanessa LaskinRobyn RoscoeKasmintan A SchraderStephen ChiaStephen YipWinson Y CheungKaren A GelmonAly KarsanDaniel J RenoufMarco MarraDean A RegierPublished in: Molecular genetics & genomic medicine (2017)
WGA costs decreased over the studied time horizon, but expenditures needed to realize WGA remain significant. Future research exploring costs and benefits of WGA-guided cancer care are crucial to guide health policy.